시장보고서
상품코드
1770815

일회용 바이오리액터 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측 : 제품 유형별, 세포 유형별, 분자 유형별, 용도별, 최종 용도별, 지역별, 경쟁별(2020-2030년)

Single-Use Bioreactors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Type, By Type of Cell, By Molecule, By Application, By Usage, By End User, By Region & Competition, 2020-2030F

발행일: | 리서치사: TechSci Research | 페이지 정보: 영문 180 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

일회용 바이오리액터(서브 테마) 세계 시장은 2024년에 23억 달러로 평가되었으며, 예측 기간 동안 CAGR 12.85%로 성장하여 2030년에는 47억 5,000만 달러에 달할 것으로 예측됩니다.

시장 성장을 주도하는 것은 연구개발 활동의 활성화, 공동 연구의 확대, 새로운 백신 및 치료제에 대한 수요 증가입니다. 만성질환 및 감염성 질환의 증가와 함께 단클론항체의 시장 개척은 시장 확대를 더욱 촉진하고 있으며, SUB는 기존의 스테인리스 스틸 시스템을 대체할 수 있는 확장성과 비용 효율성이 뛰어나 임상 및 상업용 생산에 매력적인 대안이 될 수 있습니다. 매력적인 제품입니다.

시장 개요
예측 기간 2026-2030년
시장 규모 : 2024년 23억 달러
시장 규모 : 2030년 47억 5,000만 달러
CAGR : 2025-2030년 12.85%
급성장 부문 유전자 재조합 세포
최대 시장 북미

예를 들어, 2022년 1월, HaemaLogiX Ltd는 Lonza와 제휴하여 κ 골수종 항원을 표적으로 하는 단클론항체 KappaMab의 임상 배치를 생산했습니다. 또한, 생물학적 제제의 급속한 보급, 생물학적 제제 연구에 대한 정부의 자금 지원, 맞춤형 의료에 대한 관심 증가는 전 세계 제약 및 바이오의약품 부문 전반에 걸쳐 SUB에 대한 수요를 촉진하고 있습니다. 오염 위험 감소, 처리 시간 단축, 최소한의 세척 요구 사항 등의 장점으로 인해 SUB는 최신 바이오 공정 작업에서 점점 더 필수적인 요소가 되고 있습니다.

시장 촉진요인

바이오의약품 수요와 바이오시밀러 생산 급증

주요 시장 동향

바이오프로세스에 디지털 기술 통합

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 일회용 바이오리액터 시장 전망

  • 시장 규모 및 예측
    • 금액별
  • 시장 점유율과 예측
    • 제품별(일회용 바이오리액터 시스템, 일회용 미디어 백, 일회용 여과 어셈블리, 기타 제품)
    • 유형별(교반조형 SUB, 파동 야기형 SUB, 기포탑형 SUB, 기타 SUB)
    • 세포 종류별(포유류 세포, 세균 세포, 효모 세포, 기타 세포)
    • 분자별(단클론항체, 백신, 유전자 재조합 세포, 줄기세포, 기타 분자)
    • 용도별(연구개발, 바이오 프로덕션)
    • 용도별(실험실 스케일 생산, 파일럿 스케일 생산, 대규모 생산)
    • 최종사용자별(제약회사, 바이오의약품 회사, CROS 및 CMOS, 학술조사기관)
    • 지역별(북미, 유럽, 아시아태평양, 남미, 중동 및 아프리카)
    • 기업별(2024)
  • 시장 맵
  • 제품별
  • 유형별
  • 세포 종류별
  • 분자별
  • 용도별
  • 용도별
  • 최종사용자별
  • 지역별

제6장 북미의 일회용 바이오리액터 시장 전망

  • 시장 규모 및 예측
  • 시장 점유율과 예측
  • 북미 : 국가별 분석
    • 미국
    • 캐나다
    • 멕시코

제7장 유럽의 일회용 바이오리액터 시장 전망

  • 시장 규모 및 예측
  • 시장 점유율과 예측
  • 유럽 : 국가별 분석
    • 프랑스
    • 독일
    • 영국
    • 이탈리아
    • 스페인

제8장 아시아태평양의 일회용 바이오리액터 시장 전망

  • 시장 규모 및 예측
  • 시장 점유율과 예측
  • 아시아태평양 : 국가별 분석
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주

제9장 남미의 일회용 바이오리액터 시장 전망

  • 시장 규모 및 예측
  • 시장 점유율과 예측
  • 남미 : 국가별 분석
    • 브라질
    • 아르헨티나
    • 콜롬비아

제10장 중동 및 아프리카의 일회용 바이오리액터 시장 전망

  • 시장 규모 및 예측
  • 시장 점유율과 예측
  • 중동 및 아프리카 : 국가별 분석
    • 남아프리카공화국
    • 사우디아라비아
    • 아랍에미리트

제11장 시장 역학

  • 성장 촉진요인
  • 실험실 자동화 활동 수요 증가
  • 바이오뱅크에 의한 검사 정보학의 도입 확대
  • 기술적으로 진보한 소프트웨어 서비스의 도입 증가
  • 과제
  • 연구실 정보과학의 통합 표준의 결여
  • 엄격한 규제

제12장 시장 동향과 발전

  • 최근 동향
  • 인수합병
  • 제품 출시

제13장 세계의 일회용 바이오리액터 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

  • 업계내 경쟁
  • 신규 참여의 가능성
  • 공급업체의 능력
  • 고객의 능력
  • 대체품의 위협

제15장 경쟁 구도

  • ABEC, INC.
  • Able Corporation & Biott Corporation.
  • BBI-Biotech Gmbh.
  • Cellexus Biosystems PLC.
  • Celltainer Biotech BV.
  • Danaher Corporation
  • Distek Inc.
  • Eppendorf AG.
  • G&G Technologies, Inc.
  • Getinge AB

제16장 전략적 제안

제17장 조사 회사 소개 및 면책사항

ksm 25.07.18

The Global Single-Use Bioreactors (SUBs) Market was valued at USD 2.30 billion in 2024 and is projected to reach USD 4.75 billion by 2030, growing at a CAGR of 12.85% during the forecast period. The market's growth is driven by increasing research and development activities, expanding collaborations, and heightened demand for novel vaccines and therapeutics. The rise in chronic and infectious diseases, along with the growing development of monoclonal antibodies, further supports market expansion. SUBs offer a scalable and cost-efficient alternative to traditional stainless-steel systems, making them attractive for both clinical and commercial manufacturing.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 2.30 Billion
Market Size 2030USD 4.75 Billion
CAGR 2025-203012.85%
Fastest Growing SegmentGene Modified Cells
Largest MarketNorth America

For instance, in January 2022, HaemaLogiX Ltd partnered with Lonza to manufacture a clinical batch of KappaMab, a monoclonal antibody targeting kappa myeloma antigen-demonstrating the role of SUBs in advanced drug development. Additionally, the rapid adoption of biologics, government funding for biologics research, and increased focus on personalized medicine are fostering demand for SUBs across global pharmaceutical and biopharmaceutical sectors. Their benefits, including reduced contamination risk, shorter turnaround times, and minimal cleaning requirements, make them increasingly indispensable in modern bioprocessing operations.

Key Market Drivers

Surge in Biopharmaceutical Demand and Biosimilar Production

The growing demand for biopharmaceutical products-particularly monoclonal antibodies, vaccines, and biosimilars-is a major driver of the single-use bioreactors market. These biologics are increasingly used to treat chronic diseases such as cancer, diabetes, and autoimmune disorders due to their targeted therapeutic effects and lower side effect profiles. SUBs offer a flexible and efficient production solution, reducing the need for time-consuming cleaning and sterilization compared to stainless-steel systems.

Supportive regulatory environments and rising public investment in biologics research are accelerating this shift. For instance, as of March 2024, the U.S. National Institutes of Health allocated USD 47.6 billion in funding, emphasizing biologics and biosimilar development. Similarly, the European Medicines Agency approved a notable number of monoclonal antibodies in 2023. These advancements, alongside favorable government policies, are promoting the adoption of SUBs to meet the evolving demands of large-scale and cost-effective biomanufacturing.

Key Market Trends

Integration of Digital Technologies in Bioprocessing

The integration of digital tools such as IoT, AI, and machine learning into SUB platforms is revolutionizing biomanufacturing practices. These technologies enable real-time monitoring, predictive analytics, and advanced process control-enhancing efficiency, product quality, and compliance.

Referred to as Bioprocessing 4.0, this evolution is being actively supported by regulatory agencies. For example, the U.S. FDA is encouraging the adoption of advanced manufacturing technologies to boost production resilience and safety. As a result, biopharmaceutical firms are increasingly investing in digitalized SUB systems, enabling smarter, faster, and more agile production processes. This synergy between single-use bioreactor platforms and digital transformation is expected to drive sustained improvements in scalability, traceability, and operational performance in the bioprocessing sector.

Key Market Players

  • ABEC, INC.
  • Able Corporation & Biott Corporation
  • BBI-Biotech GmbH
  • Cellexus Biosystems PLC
  • Celltainer Biotech BV
  • Danaher Corporation
  • Distek Inc.
  • Eppendorf AG
  • G&G Technologies, Inc.
  • Getinge AB

Report Scope:

In this report, the Global Single-Use Bioreactors Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Single-Use Bioreactors Market, By Product:

  • Single use bioreactor systems
  • Single use media bags
  • Single use filtration assemblies
  • Other products

Single-Use Bioreactors Market, By Type:

  • Stirred tank SUB
  • Wave induced SUB
  • Bubble Column SUB
  • Other SUB

Single-Use Bioreactors Market, By Type of Cell:

  • Mammalian Cell
  • Bacterial Cell
  • Yeast Cell
  • Other Cells

Single-Use Bioreactors Market, By Molecule:

  • Monoclonal Antibodies
  • Vaccines
  • Gene Modified Cells
  • Stem Cells
  • Other molecules

Single-Use Bioreactors Market, By Application:

  • Research and Development
  • Bioproduction

Single-Use Bioreactors Market, By Usage:

  • Lab scale production
  • Pilot scale production
  • Large scale production

Single-Use Bioreactors Market, By End User:

  • Pharmaceutical and Biopharmaceutical companies
  • CROSs & CMOS
  • Academic and Research Institutes

Single-Use Bioreactors Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Single-Use Bioreactors Market.

Available Customizations:

Global Single-Use Bioreactors Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Single-Use Bioreactors Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
    • 5.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
    • 5.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
    • 5.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
    • 5.2.5. By Application (Research and Development, Bioproduction)
    • 5.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
    • 5.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
    • 5.2.8. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 5.2.9. By Company (2024)
  • 5.3. Market Map
  • 5.3.1 By Product
  • 5.3.2 By Type
  • 5.3.3 By Type of Cell
  • 5.3.4 By Molecule
  • 5.3.5 By Application
  • 5.3.6 By Usage
  • 5.3.7 By End User
  • 5.3.5 By Region

6. North America Single-Use Bioreactors Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
    • 6.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
    • 6.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
    • 6.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
    • 6.2.5. By Application (Research and Development, Bioproduction)
    • 6.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
    • 6.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
    • 6.2.8. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Single-Use Bioreactors Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Type
        • 6.3.1.2.3. By Type of Cell
        • 6.3.1.2.4. By Molecule
        • 6.3.1.2.5. By Application
        • 6.3.1.2.6. By Usage
        • 6.3.1.2.7. By End User
    • 6.3.2. Canada Single-Use Bioreactors Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Type
        • 6.3.2.2.3. By Type of Cell
        • 6.3.2.2.4. By Molecule
        • 6.3.2.2.5. By Application
        • 6.3.2.2.6. By Usage
        • 6.3.2.2.7. By End User
    • 6.3.3. Mexico Single-Use Bioreactors Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Type
        • 6.3.3.2.3. By Type of Cell
        • 6.3.3.2.4. By Molecule
        • 6.3.3.2.5. By Application
        • 6.3.3.2.6. By Usage
        • 6.3.3.2.7. By End User

7. Europe Single-Use Bioreactors Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
    • 7.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
    • 7.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
    • 7.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
    • 7.2.5. By Application (Research and Development, Bioproduction)
    • 7.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
    • 7.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
    • 7.2.8. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Single-Use Bioreactors Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Type
        • 7.3.1.2.3. By Type of Cell
        • 7.3.1.2.4. By Molecule
        • 7.3.1.2.5. By Application
        • 7.3.1.2.6. By Usage
        • 7.3.1.2.7. By End User
    • 7.3.2. Germany Single-Use Bioreactors Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Type
        • 7.3.2.2.3. By Type of Cell
        • 7.3.2.2.4. By Molecule
        • 7.3.2.2.5. By Application
        • 7.3.2.2.6. By Usage
        • 7.3.2.2.7. By End User
    • 7.3.3. United Kingdom Single-Use Bioreactors Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Type
        • 7.3.3.2.3. By Type of Cell
        • 7.3.3.2.4. By Molecule
        • 7.3.3.2.5. By Application
        • 7.3.3.2.6. By Usage
        • 7.3.3.2.7. By End User
    • 7.3.4. Italy Single-Use Bioreactors Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Type
        • 7.3.4.2.3. By Type of Cell
        • 7.3.4.2.4. By Molecule
        • 7.3.4.2.5. By Application
        • 7.3.4.2.6. By Usage
        • 7.3.4.2.7. By End User
    • 7.3.5. Spain Single-Use Bioreactors Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Type
        • 7.3.5.2.3. By Type of Cell
        • 7.3.5.2.4. By Molecule
        • 7.3.5.2.5. By Application
        • 7.3.5.2.6. By Usage
        • 7.3.5.2.7. By End User

8. Asia-Pacific Single-Use Bioreactors Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
    • 8.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
    • 8.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
    • 8.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
    • 8.2.5. By Application (Research and Development, Bioproduction)
    • 8.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
    • 8.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
    • 8.2.8. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Single-Use Bioreactors Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Type
        • 8.3.1.2.3. By Type of Cell
        • 8.3.1.2.4. By Molecule
        • 8.3.1.2.5. By Application
        • 8.3.1.2.6. By Usage
        • 8.3.1.2.7. By End User
    • 8.3.2. India Single-Use Bioreactors Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Type
        • 8.3.2.2.3. By Type of Cell
        • 8.3.2.2.4. By Molecule
        • 8.3.2.2.5. By Application
        • 8.3.2.2.6. By Usage
        • 8.3.2.2.7. By End User
    • 8.3.3. Japan Single-Use Bioreactors Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Type
        • 8.3.3.2.3. By Type of Cell
        • 8.3.3.2.4. By Molecule
        • 8.3.3.2.5. By Application
        • 8.3.3.2.6. By Usage
        • 8.3.3.2.7. By End User
    • 8.3.4. South Korea Single-Use Bioreactors Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Type
        • 8.3.4.2.3. By Type of Cell
        • 8.3.4.2.4. By Molecule
        • 8.3.4.2.5. By Application
        • 8.3.4.2.6. By Usage
        • 8.3.4.2.7. By End User
    • 8.3.5. Australia Single-Use Bioreactors Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Type
        • 8.3.5.2.3. By Type of Cell
        • 8.3.5.2.4. By Molecule
        • 8.3.5.2.5. By Application
        • 8.3.5.2.6. By Usage
        • 8.3.5.2.7. By End User

9. South America Single-Use Bioreactors Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
    • 9.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
    • 9.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
    • 9.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
    • 9.2.5. By Application (Research and Development, Bioproduction)
    • 9.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
    • 9.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
    • 9.2.8. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Single-Use Bioreactors Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Type
        • 9.3.1.2.3. By Type of Cell
        • 9.3.1.2.4. By Molecule
        • 9.3.1.2.5. By Application
        • 9.3.1.2.6. By Usage
        • 9.3.1.2.7. By End User
    • 9.3.2. Argentina Single-Use Bioreactors Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Type
        • 9.3.2.2.3. By Type of Cell
        • 9.3.2.2.4. By Molecule
        • 9.3.2.2.5. By Application
        • 9.3.2.2.6. By Usage
        • 9.3.2.2.7. By End User
    • 9.3.3. Colombia Single-Use Bioreactors Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Type
        • 9.3.3.2.3. By Type of Cell
        • 9.3.3.2.4. By Molecule
        • 9.3.3.2.5. By Application
        • 9.3.3.2.6. By Usage
        • 9.3.3.2.7. By End User

10. Middle East and Africa Single-Use Bioreactors Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
    • 10.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
    • 10.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
    • 10.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
    • 10.2.5. By Application (Research and Development, Bioproduction)
    • 10.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
    • 10.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
    • 10.2.8. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Single-Use Bioreactors Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Type
        • 10.3.1.2.3. By Type of Cell
        • 10.3.1.2.4. By Molecule
        • 10.3.1.2.5. By Application
        • 10.3.1.2.6. By Usage
        • 10.3.1.2.7. By End User
    • 10.3.2. Saudi Arabia Single-Use Bioreactors Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Type
        • 10.3.2.2.3. By Type of Cell
        • 10.3.2.2.4. By Molecule
        • 10.3.2.2.5. By Application
        • 10.3.2.2.6. By Usage
        • 10.3.2.2.7. By End User
    • 10.3.3. UAE Single-Use Bioreactors Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Type
        • 10.3.3.2.3. By Type of Cell
        • 10.3.3.2.4. By Molecule
        • 10.3.3.2.5. By Application
        • 10.3.3.2.6. By Usage
        • 10.3.3.2.7. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.1.1 Growing demand for lab automation activities
  • 11.1.2 Growing adoption of lab informatics by biobanks
  • 11.1.3 Growing introduction of technologically advanced software services
  • 11.2. Challenges
  • 11.2.1 Lack of integration standards for laboratory informatics
  • 11.2.2 Stringent Regulations

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Single-Use Bioreactors Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. ABEC, INC.
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Able Corporation & Biott Corporation.
  • 15.3. BBI-Biotech Gmbh.
  • 15.4. Cellexus Biosystems PLC.
  • 15.5. Celltainer Biotech BV.
  • 15.6. Danaher Corporation
  • 15.7. Distek Inc.
  • 15.8. Eppendorf AG.
  • 15.9. G&G Technologies, Inc.
  • 15.10. Getinge AB

16. Strategic Recommendations

17. About Us & Disclaimer

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제